all stories

Spyre Therapeutics (NASDAQ:SYRE) CFO Scott Burrows Sells 7,500 Shares

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 6 August 2026

What it is about

Scott BurrowsAmerica CorpWolfe ResearchWells Fargo CompanyNasdaqPerceptive AdvisorsCitigroupAmerica

Who published it, and when

How it spread - 1 original report

  1. Thu, 6 August 2026

    1 report
    • themarketsdaily.com03:08first to report

      Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CFO Scott Burrows sold 7,500 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $95.57, for a total transaction of $716,775.00. Following the completion of the transaction, the chief financial officer owned 97,994 shares in […]

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.